Matthias Hepprich

Head of Department

St. Claraspital

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthias Hepprich is the Head of Department at St. Claraspital in Switzerland. His research interests include the diagnosis and treatment of hypoglycemia, the role of inflammation in metabolic disorders, and the impact of fasting on health. He has contributed to various studies on glucocorticoid effects, diabetic complications, and clinical trials related to COVID-19 and diabetes management.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

Michael Sack

National Heart Lung and Blood Institute

UNITED STATES

View details

Lia Bally

SWITZERLAND

View details

Christina M. Berr

Lecturer, Physician Scientist

GERMANY

View details

Claudia Cavelti-Weder

Leitende Ärztin (chief of service)

University Hospital of Zurich

SWITZERLAND

View details

Damian Wild

Head of Nuclear Medicine

University Hospital Basel

SWITZERLAND

View details

Luca Cossu

University of Padova

ITALY

View details

Anne Wojtusciszyn

prof.

Lausanne University Hospital

SWITZERLAND

View details

Marco Cattaneo

University of Basel

SWITZERLAND

View details

Philipp A Gerber

SWITZERLAND

View details

Aditya Kotecha

The University of Alabama

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Hepprich

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study

Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study

Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting

Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass

Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey

Dyslipidaemia and growth hormone deficiency – A comprehensive review

Glucocorticoid withdrawal and glucocorticoidinduced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19

Collaborators (10)

Michael Sack

Lia Bally

Christina M. Berr

Claudia Cavelti-Weder

Damian Wild

Luca Cossu

Anne Wojtusciszyn

Marco Cattaneo

Philipp A Gerber

Aditya Kotecha

Make your next move.